Active	Status	Sponsor type	Region	Phase	Filter
4 Active 8 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Melmed, Raun
NCT05067582: A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder	Active, not recruiting	2	58	US	L1-79, DL-alpha-Methyltyrosine	Yamo Pharmaceuticals LLC	Autism Spectrum Disorder, Autism	06/24	07/24
MAP, NCT04672967: Autism Prediction Study	Recruiting	N/A	200	US	BioROSA MAP test	BioROSA Technologies Inc, Melmed Center, Vanderbilt University	Autism Spectrum Disorder, Developmental Delay	05/22	10/22
Chavez, Brian
No trials found